Cargando…

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain

Human papillomavirus (HPV) is one of the main causes of infection-related cancer. The bivalent vaccine (2vHPV) (16/18) and quadrivalent (6/11/16/18) HPV vaccine (4vHPV) have been included in the Spanish vaccination calendar since 2007. The new nonavalent HPV vaccine (9vHPV), approved in Europe in 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	De La Fuente, Jesús, Hernandez Aguado, Juan José, San Martín, María, Ramirez Boix, Paula, Cedillo Gómez, Sergio, López, Noelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746536/ https://www.ncbi.nlm.nih.gov/pubmed/30698488 http://dx.doi.org/10.1080/21645515.2018.1560770

Ejemplares similares

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
por: Petry, Karl-Ulrich, et al.
Publicado: (2018)

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015)

Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2017)

Correction to: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2018)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
por: Bosco, Liana, et al.
Publicado: (2021)

Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain
por: Linertová, Renata, et al.
Publicado: (2022)

Age-Related Changes in the Fraction of Cervical Intraepithelial Neoplasia Grade 3 Related to HPV Genotypes Included in the Nonavalent Vaccine
por: Giannella, Luca, et al.
Publicado: (2019)

Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine
por: López, Noelia, et al.
Publicado: (2018)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
por: Capra, Giuseppina, et al.
Publicado: (2017)

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult
por: Ferguson, Sara B., et al.
Publicado: (2017)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
por: Pizzatti, Laura, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study
por: Gilca, Vladimir, et al.
Publicado: (2018)

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series
por: BOSSART, Simon, et al.
Publicado: (2020)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021)

Commentary The Importance of Cost Estimation for Molecular Epidemiology Studies
por: La Vecchia, Carlo
Publicado: (2016)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
por: Hernandez-Aguado, Juan J., et al.
Publicado: (2022)

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
por: Ibáñez, R., et al.
Publicado: (2021)

Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study
por: Boix, R., et al.
Publicado: (2017)

Animal Protection in Filming in the Context of Spain
por: De Damborenea Martín, Pablo, et al.
Publicado: (2023)

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review
por: Núñez, Mercedes, et al.
Publicado: (2019)

Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
por: Purriños-Hermida, M. Jesus, et al.
Publicado: (2018)

Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
por: Castellsagué, Xavier, et al.
Publicado: (2009)

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
por: Fanciulli, Chiara, et al.
Publicado: (2022)

Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain
por: Cebrián-Cuenca, Ana M, et al.
Publicado: (2011)

Occupation and Sickness Absence in the Different Autonomous Communities of Spain
por: Alba-Jurado, Matilde Leonor, et al.
Publicado: (2021)

First epidemiological survey of Angiostrongylus vasorum in domestic dogs from Spain
por: Carretón, Elena, et al.
Publicado: (2020)

Scabies in Spain? A comprehensive epidemiological picture
por: Redondo-Bravo, Lidia, et al.
Publicado: (2021)

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
por: Hernández-López, Rubí, et al.
Publicado: (2019)

Molecular epidemiology of Kaposi sarcoma virus in Spain
por: Gómez, Inmaculada, et al.
Publicado: (2022)

Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019
por: Peñuelas, Marina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_500el0352fv2vbkagjhea4fmkd